AGC Equity Partners

Conformis, Inc. is a medical technology company based in Billerica, Massachusetts, specializing in the development, manufacturing, and sale of personalized joint replacement implants and instruments. Utilizing its proprietary iFit® Image-to-Implant® technology platform, Conformis creates individually sized and shaped implants tailored to fit each patient's unique anatomy. The company's product offerings include various knee replacement systems, such as iTotal CR, iTotal PS, iDuo, and iUni, as well as the Conformis Hip System and customized single-use instrumentation known as iJigs. Conformis markets its products primarily to hospitals and ambulatory surgical centers through a combination of its sales force, independent representatives, and distributors in multiple countries, including the United States and several European and Asian markets. The company emphasizes superior clinical outcomes and patient satisfaction compared to traditional off-the-shelf implants.

Evernote Corporation develops and markets applications for mobile phones, tablets, and computers, catering to individuals and businesses globally. The company's flagship product, Evernote, allows users to write, collect, and present information from a single workspace, enhancing productivity and organization. In addition to Evernote, the company offers several complementary tools, including Skitch for visual communication through annotations and sketches, Scannable for digitizing paper documents, Evernote Web Clipper for saving online content, and Penultimate, a handwriting app for iPad users. Founded in 2007 and headquartered in Redwood City, California, Evernote has grown to serve over 100 million users worldwide, providing a freemium service that enables seamless synchronization of data across multiple devices and operating systems.

Conformis, Inc. is a medical technology company based in Billerica, Massachusetts, specializing in the development, manufacturing, and sale of personalized joint replacement implants and instruments. Utilizing its proprietary iFit® Image-to-Implant® technology platform, Conformis creates individually sized and shaped implants tailored to fit each patient's unique anatomy. The company's product offerings include various knee replacement systems, such as iTotal CR, iTotal PS, iDuo, and iUni, as well as the Conformis Hip System and customized single-use instrumentation known as iJigs. Conformis markets its products primarily to hospitals and ambulatory surgical centers through a combination of its sales force, independent representatives, and distributors in multiple countries, including the United States and several European and Asian markets. The company emphasizes superior clinical outcomes and patient satisfaction compared to traditional off-the-shelf implants.